三诺生物

300298.SZ

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健设备与用品 > 医疗保健设备

公司成立于2002年，是一家致力于利用生物传感技术研发、生产、销售快速检测慢性疾病产品的高新技术企业。公司始终秉承“恪守承诺、奉献健康”的企业宗旨，专注推进糖尿病及慢病健康事业的高质量发展。在“为爱而诺”核心价值观的引领下，公司通过持续创新，从“中国血糖仪普及推动者”发展成为“全球领先的代谢病监测专家”，并以“全球领先的糖尿病数字管理专家”为战略愿景，不断深耕慢病健康管理领域，以技术创新赋能行业发展与大众健康。公司将聚焦生物传感技术创新，利用人工智能技术日趋成熟的发展机遇，围绕重大慢病筛查与管理的临床需求及用户需求，将其转化为科学问题并开展系统性研究，进而实现技术突破，并进一步将技术成果转化为产品与服务应用。公司积极探索“生物传感+人工智能+医疗”融合发展新模式，构建“感知+评估+干预”一体化的糖尿病智慧管理闭环，为慢病防治提供更多创新性、系统性的智慧医疗解决方案，持续提升糖尿病等慢病患者的生活质量，致力成为全球领先的糖尿病数字管理专家。

ESG Score Industry Ranking:
6 / 151 (医疗保健设备与用品)

ESG Rating Distribution(医疗保健设备与用品)

0.66%

AAA

3.31%

15.23%

21.19%

BBB

49.67%

7.95%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：7.90Updated on 2026-10-29

07.9010

Management & Practices Score：4.93Updated on 2026-10-18

04.937

Controversies Score：2.98Updated on 2026-10-29

02.983

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	5.48	2.78	5.84%
Social	6.97	3.82	65.37%
Governance	7.51	5.86	28.77%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(151 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	688139.SH	海尔生物	AAA	8.91	2.98	5.93	8.20	8.84	7.69
2	002223.SZ	鱼跃医疗	AA	8.44	2.97	5.47	7.99	7.85	7.72
3	300760.SZ	迈瑞医疗	AA	8.41	2.99	5.42	6.67	7.34	8.87
4	300888.SZ	稳健医疗	AA	8.37	3.00	5.38	7.76	7.52	8.03
5	688029.SH	南微医学	AA	8.09	2.99	5.10	6.96	7.48	6.88
6	300298.SZ	三诺生物	AA	7.90	2.98	4.93	5.48	6.97	7.51
7	605369.SH	拱东医疗	A	7.85	2.97	4.88	4.37	7.00	7.42
8	300981.SZ	中红医疗	A	7.77	2.97	4.80	2.82	6.96	7.44
9	300832.SZ	新产业	A	7.75	2.88	4.87	4.67	6.99	7.35
10	0853.HK	微创医疗	A	7.72	2.90	4.82	6.88	7.64	5.17